Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they ...

OPKO Health strengthens finances by selling BioReference and focusing on drug development. Click here to read an analysis of ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Simple Promise's Revolutionary GLP-1 Electrolyte Formula Blends Hydration with Metabolic Support for Real, Sustainable Weight ...